OmniAb Inc. (OABI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $713.26M
Last updated: Nov 17, 2026 at 4:23 PM ET
OmniAb Inc. (OABI) Statistics
OmniAb (OABI) has a market cap of $713.26M and an enterprise value of $705.30M. It kept -108.11% of revenue as net income over the last 12 months. Revenue grew 90.63% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 1.12% below the market cap, as cash exceeds debt.
| Market Cap | $713.26M |
|---|---|
| Enterprise Value | $705.30M |
| Latest price (Nov 17, 2026) | $5.05 |
Key Dates
The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 2, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 30, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 16.2x and 2.6x. Its year-end P/S ranged from 5.4x to 18.0x from 2022 to 2025.
| P/S Ratio | 16.2x |
|---|---|
| Forward P/S | 19.2x |
| P/B Ratio | 2.6x |
| P/TBV Ratio | 12.5x |
| P/OCF Ratio | 267.5x |
Price Statistics
The stock is up 223.72% over 52 weeks and trades 5.87% above its 50-day average.
| Beta (1Y) | 1.25 |
|---|---|
| 52-Week Change | +223.72% |
| 1-Month Change | +7.68% |
| 3-Month Change | +20.53% |
| 6-Month Change | +113.08% |
| Total Return (1Y) | +223.72% |
| Total Return (3Y CAGR) | +4.31% |
| Return vs SPY (1Y) | +202.11% |
| Max Drawdown (1Y) | -37.04% |
| Max Drawdown (3Y) | -81.32% |
| Sharpe Ratio (1Y) | 1.61 |
| Correlation with SPY (1Y) | 0.24 |
| 50-Day Average | $4.77 |
| 200-Day Average | $2.89 |
| 52-Week Range | $1.35 to $5.45 |
| RSI (14 Days) | 53.6 |
| Average Volume (20 Days) | 1.53M |
Financial Position
Current assets cover 4.21x current liabilities, and total debt is 0.06x shareholder equity.
| Current Ratio | 4.21x |
|---|---|
| Quick Ratio | 4.21x |
| Debt / Equity | 0.06x |
Returns and Efficiency
Return on invested capital is -17.46% over the last 12 months, against a 5-year average of -23.68%.
| Return on Equity (ROE) | -17.45% |
|---|---|
| Return on Assets (ROA) | -14.94% |
| Return on Invested Capital (ROIC) | -17.46% |
| ROE (5Y Average) | -16.00% |
| ROA (5Y Average) | -13.65% |
| ROIC (5Y Average) | -23.68% |
| Asset Turnover | 0.13x |
| Receivables Turnover | 6.23x |
Scores
OABI has an Altman Z-Score of 8.27, in the safe zone above 2.99, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 8.27 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 1 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was $40.21M over the last 12 months.
| Revenue | $40.21M |
|---|---|
| Revenue Growth (YoY) | +90.63% |
| Gross Profit | $39.27M |
| Operating Income | -$46.60M |
| Pretax Income | -$43.88M |
| Net Income | -$43.47M |
| EBITDA | -$23.99M |
| Reported EPS (TTM) | -$0.34 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 85.65% of the $290.92M in total assets.
| Cash and Equivalents | $22.88M |
|---|---|
| Total Debt | $14.93M |
| Net Cash | $7.96M |
| Net Cash Per Share | $0.06 |
| Working Capital | $54.13M |
| Shareholder Equity | $249.16M |
| Book Value Per Share | $1.93 |
| Tangible Book Value | $52.17M |
| Tangible Book Per Share | $0.40 |
| Total Assets | $290.92M |
| Total Liabilities | $41.76M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | $2.67M |
|---|---|
| FCF Per Share | $0.02 |
| Depreciation and Amortization | $23.05M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -115.89%.
| Gross Margin | 97.65% |
|---|---|
| Operating Margin | -115.89% |
| Pretax Margin | -109.12% |
| Net Margin | -108.11% |
| EBITDA Margin | -59.65% |
| Gross Margin (5Y Average) | 99.68% |
Growth
Revenue fell 31.89% a year over 3 years.
| Revenue Growth (3Y CAGR) | -31.89% |
|---|---|
| Revenue Growth (5Y CAGR) | -4.31% |
| Book Value Per Share Growth (2Y CAGR) | -18.43% |
| Tangible Book Per Share Growth (2Y CAGR) | -22.29% |
Dividends and Yields
OABI does not pay a dividend.
| Buyback Yield | -0.32% |
|---|---|
| Shareholder Yield | -0.32% |
Peer Position
Against 4 similar companies, OABI has the 4th highest P/S.
P/S RatioPeer median 65.1x
ROICPeer median -46.80%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -100.00%
| P/S Ratio | 16.2x vs 65.1x median |
|---|---|
| ROIC | -17.46% vs -46.80% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +90.63% vs -100.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 58.67% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +58.67% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OABI
What is OABI's market cap?
OmniAb has a market cap of $713.26M. Its enterprise value, which adds debt and subtracts cash, is $705.30M.
How many shares of OABI are outstanding?
OmniAb has 129.29M shares outstanding. The count is up 12.70% from a year earlier.
Does OABI pay a dividend?
No. OmniAb does not pay a dividend.
How much debt does OABI have?
OmniAb has $14.93M of total debt and $22.88M of cash and equivalents, a net cash position of $7.96M.
OABI pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors